Click on headlines below to download research
New name, new business, new shareholder
SGT German Private Equity | 20/10/2020
SGT German Private Equity (SGT, formerly German Startups Group, GSG) reported a minor €0.2m net loss in H120, following the deconsolidation of Exozet…
Seeking secular growth augmented with M&A
Deutsche Börse | 19/10/2020
Deutsche Börse (DB1) is a leading European capital markets infrastructure provider with activities across pre-trading, trading and clearing, and post-trade…
Focus on building scale
Lloyd Fonds | 19/10/2020
Lloyd Fonds (LF) continues its operational realignment process with Strategy 2023/2025 initiated in FY20. The new business model has been implemented under…
German private equity investor and manager
Deutsche Beteiligungs | 19/10/2020
Deutsche Beteiligungs (DBAG) is a well-established private equity company investing primarily in mid-sized German companies. It also manages €2.1bn…
EKF interview
Evolva – EKF interview | 19/10/2020
Evolva is a Swiss biotech company focused on the research, development and commercialisation of ingredients based on nature. It has leading businesses…
EKF interview
EQS Group - EKF interview | 19/10/2020
EQS CEO Achim Weick and CFO André Silvério Marques describe how the group's COCKPIT platform helps its clients run their businesses and meet…
Commercialisation of remimazolam underway
Paion | 15/10/2020
Paion has gained approvals in the US, China and Japan for its fast-onset, short-recovery anaesthesia product remimazolam. In the US, partner Acacia is…
Resilient H1, flurry of H2 contracts
artec technologies | 15/10/2020
H120 sales of €1.3m (up 43% from H119) represented a resilient first-half performance for artec, given the impact of the COVID-19 pandemic. Management…
Leading global football brand
Borussia Dortmund | 15/10/2020
The 2019/20 season was typically successful from a sporting perspective, which reaffirmed Borussia Dortmund’s position as one of the leading football…
Grateful for volatility
Flatex | 14/10/2020
Flatex reported H120 earnings of €22.4m (+162% y-o-y) and ROE of 23.1%. Volatile markets helped trade executions jump 127% y-o-y to €13.1m.…
Striding towards major inflection pointsDE000A0HGQF5magforce141020qv.pdf
MagForce | 14/10/2020
MagForce, a pioneer in nanotechnology-based cancer treatments, is making steady progress with its strategy to drive the uptake of its thermal ablation…
Another brick in the yellow wall
Borussia Dortmund | 14/10/2020
The 2019/20 season was typically successful from a sporting perspective, which reaffirmed Borussia Dortmund’s position as one of the leading football…
Profitable again in H120 with further upside
Daldrup & Söhne | 13/10/2020
Daldrup & Söhne reported a strong set of results in H120, with minimal impact from the coronavirus-pandemic. Total output increased by 5% to €23m,…
Strengthening the second business pillar
publity | 12/10/2020
As publity shifts towards a two-pillar business model, focused on real estate asset management and investment, its portfolio of fully owned properties…
A platform for sustainable growth
EQS Group | 12/10/2020
With ever-increasing requirements and growing complexity in corporate reporting, EQS has a positive backdrop for its products and services in digital investor…
Disposal standstill in Q220
RCM Beteiligungs | 08/10/2020
In H120, RCM Beteiligungs group reported €10.2m in revenues against €19.2m in H119. The decline was attributable to a lower volume of property…
Positive catalysts at portfolio holdings
FinLab | 07/10/2020
FinLab posted a strong NAV total return in H120 (+9.5%), driven by the solid share price performance of its only listed holding, Heliad Equity Partners…
Recovery in H220 will deliver FY20 break-even
DVS Technology | 07/10/2020
DVS TECHNOLOGY’s H120 results were affected by a lower order book at the start of the year and the coronavirus pandemic, leading to a 28% decline…
Connectivity for the skies and beyond
Mynaric | 06/10/2020
Mynaric has developed equipment for transmitting data via laser between moving airborne or space platforms at rates similar to conventional optical fibre…
Focus remains on reverse takeover
mic | 01/10/2020
mic’s corporate structure has not changed during H120 and the company is still searching for a reverse takeover target, which should transform it…
Two submissions and two Phase III trials in 2021
Formycon | 30/09/2020
Formycon continues to progress three core biosimilar projects. In H220, it is preparing the FYB201 (Lucentis biosimilar) EMA approval submission and helping…
Resilient in the downturn
mVISE | 29/09/2020
A strong performance from its services business (+6% y-o-y) saw mVISE deliver growth, margin uplift and cash flow in H1 despite COVID-19. However, this…
Mynaric - executive interview
Mynaric - executive interview | 28/09/2020
Mynaric designs and manufactures laser communication terminals and ground stations for airborne and spaceborne networks and applications. Its objective…
Maintaining positive earnings momentum
Nurnberger Beteiligungs | 28/09/2020
Nürnberger Beteiligungs (NBG) has weathered the COVID-19 crisis quite well so far, with improving gross premiums booked (despite somewhat lower new…
Positive catalysts at portfolio holdings
FinLab | 25/09/2020
FinLab posted a strong NAV total return in H120 (+9.5%), driven by the solid share price performance of its only listed holding, Heliad Equity Partners…